• argenx receives positive CHMP opinion for efgartigimod for the treatment of adult patients with generalized myasthenia gravis in Europe

    Friday June 24th 2022

  • Charles River and Ziphius Vaccines collaborate to manufacture saRNA-based vaccine

    Thursday June 23rd 2022

  • Fujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry

    Thursday June 23rd 2022

  • Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies

    Wednesday June 22nd 2022

  • Biocartis announces new agreement with AstraZeneca for the development and marketing of a companion diagnostic test for Tagrisso®

    Wednesday June 22nd 2022

  • IDDI announces RTSM partnership with Clario

    Wednesday June 22nd 2022

  • Biotalys and Novozymes enter into partnership to expand opportunities for Evoca™

    Tuesday June 21st 2022

  • New agreement paves way for development of first African-owned COVID-19 vaccine

    Tuesday June 21st 2022

  • Your news here?

  • Biocartis announces launch of its rapid CE-marked IVD Idylla™ GeneFusion Panel for fast treatment decisions in lung cancer

    Monday June 20th 2022

  • Mithra announces the resignation of François Fornieri as Non-Executive Director

    Monday June 20th 2022

  • ViroVet completes series C funding

    Thursday June 16th 2022


Strategic Partners